Synthesis and antiproliferative properties of a photoactivatable analogue of ET-18-OCH 3
Tetrahedron, ISSN: 0040-4020, Vol: 57, Issue: 43, Page: 8925-8932
2001
- 14Citations
- 13Captures
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Article Description
A photoreactive analogue of the antitumor ether lipid 1- O -octadecyl-2- O -methyl-glycero-3-phosphocholine (ET-18-OCH 3, 1 ) was synthesized for the first time. The 3-(trifluoromethyl)-3-( m -iodophenyl)diazirine (TID) moiety was used as the photolabel in ether lipid 2a. The TID group was tethered through an O -undecyloxy linkage to the sn -1 position of the ether lipid. Compound 2a was found to qualitatively mimic the antiproliferative effects of 1 in the dark (i.e. in the absence of carbene generation), suggesting that this photoactivatable probe may be suitable for identification of the proteins that mediate the biological activities of 1. Analogue 2a was converted by Stille reaction to stannane intermediate 2b, which was subjected to ipso [ 125 I]-iododestannylation to afford 125 I-labeled ether lipid 2c. Photolysis (long wavelength UV light, 30 min) of 2c in the presence of cytosolic proteins obtained from a breast cancer cell line (MCF-7), followed by NaDodSO 4 /PAGE and autoradiography, showed radioiodination of primarily two polypeptides (with molecular masses of about 47- and 170-kDa), both of which were subject to competition by prior addition of excess 2a. This study indicates that analogue 2c may have utility in the characterization of the putative proteins that interact specifically with antitumor ether lipid 1.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S0040402001009012; http://dx.doi.org/10.1016/s0040-4020(01)00901-2; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=0035935123&origin=inward; https://linkinghub.elsevier.com/retrieve/pii/S0040402001009012; https://api.elsevier.com/content/article/PII:S0040402001009012?httpAccept=text/xml; https://api.elsevier.com/content/article/PII:S0040402001009012?httpAccept=text/plain; http://linkinghub.elsevier.com/retrieve/pii/S0040402001009012; http://api.elsevier.com/content/article/PII:S0040402001009012?httpAccept=text/xml; http://api.elsevier.com/content/article/PII:S0040402001009012?httpAccept=text/plain; http://dx.doi.org/10.1016/s0040-4020%2801%2900901-2; https://dx.doi.org/10.1016/s0040-4020%2801%2900901-2
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know